To what extent is the market already exposed to a single, systemic AI event and what type of claims are starting to emerge?
To what extent is the market already exposed to a single, systemic AI event and what type of claims are starting to emerge?
A growing litigation pipeline around semi-liquid private credit funds is anticipated as liquidity, valuation, and governance mechanisms face pressure.
Could directors be exposing themselves to liability in legal disputes?
What the Supreme Court’s high bar for departing from group litigation orders test case rulings means for financial services.
The change comes a few weeks after the SEC ended its own “no-deny” policy.
The judgment sends a powerful message about the limits of deceit in heavily negotiated M&A transactions and the high threshold for these types of claims.
This article covers the expanded litigation risk, the steps life science companies should take to reinforce their product safety, and risk‑management governance.
Managing escalating technology litigation risk.